Metraipolis › archive › dc_b66fc38940fb

Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors — Europe PMC PMID:42145464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42145464
DOI
10.1002/anbr.202500255
License (as archived)
solo-consultazione
Archived
2026-11-04T02:33:05.926Z
SHA-256 of the archived text
797c50f025d035a4111f1f3ca55f631461417bd73d3a4c62a8a7fcce248cba8f
Stable URL of this page
https://metraipolis.com/documento/dc_b66fc38940fb

How to cite

Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors — Europe PMC PMID:42145464 — Europe PMC (en), https://europepmc.org/article/MED/42145464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b66fc38940fb (Metraipolis archive dc_b66fc38940fb, sha256 797c50f025d035a4111f1f3ca55f631461417bd73d3a4c62a8a7fcce248cba8f)
BibTeX
@misc{dcb66fc38940fb,
  title = {Mesoporous Silica Nanoparticles With Customized Drug Ratio/Loading for Effective Treatment of Gemcitabine-Resistant Pancreatic Tumors — Europe PMC PMID:42145464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42145464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b66fc38940fb; sha256 797c50f025d035a4111f1f3ca55f631461417bd73d3a4c62a8a7fcce248cba8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42145464. Agents can read the archived copy with the MCP tool read_document.